Earlier this year, we asked you to send a message to the secretary of Health and Human Services (HHS) and the director of the National Institutes of Health (NIH) regarding the unjust pricing of the $129,000 prostate cancer drug, Xtandi. RxRights also signed on to a letter to the NIH, along with 10 other public interest … Continue to Article-->
Lee Graczyk, our lead organizer, was asked to share his expertise on the John Gambling Show on Tuesday. You can listen to the radio interview here. John’s discussion with Lee starts about 17 minutes and 30 seconds into the program.
Topics discussed include:
The fact that Medicare is prohibited from negotiating with … Continue to Article-->
By Beth Mole
Last week, as Vermont Governor Peter Shumlin signed off on the first state law requiring drug companies to justify steep price hikes, Pfizer was in the process of raising the list prices of its drugs by an average of 8.8 percent, according to a Pfizer spokesperson. The price boost follows a … Continue to Article-->
On October 15 of last year, the Department of Health and Human Services (HHS) and the FDA issued a rule giving the government the authority to seize and destroy personally imported drugs. We’ve been anxiously anticipating the fallout from this unjust regulation. And we just heard about an individual in Chicago whose … Continue to Article-->
Desperate people sometimes do desperate things. An 86-year-old man in Florida killed his wife of 50 years earlier this month. The reason he gave? She was suffering and they couldn’t afford her medicine.
This tragedy was preventable. We’ve seen that drug prices for brand name, generic and specialty drugs continue to … Continue to Article-->